Literature DB >> 17001634

Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells.

Louise M Barnes1, Catherine M Bentley, Nicola Moy, Alan J Dickson.   

Abstract

The production of recombinant proteins from mammalian cells is now an essential part of biotechnology. However, despite this importance, the detailed characteristics of good producing cell lines remain largely unknown. The industrially important GS-NS0 mammalian expression system is able to produce large amounts of protein from relatively few copies of recombinant genes. This makes GS-NS0 cell lines ideal candidates to study the consequence of recombinant plasmid transfection in mammalian cells. This study investigated the molecular features of a panel of 17 randomly chosen GS-NS0 cell lines engineered to produce a recombinant antibody. The research analysed antibody production via enzyme-linked immunosorbent assay (ELISA), and investigated the molecular features of the transfectants by Northern, Southern and copy number analysis. The cell lines generated produced a range of antibody concentrations. In addition, for transfectants defined as producers of recombinant antibody there was a positive correlation between specific productivity and heavy chain mRNA expression. The use of Northern and Southern analysis allowed determination of the functional integrity of the transfected plasmid. Over 50% of the transfectants studied had molecular defects at the level of mRNA and/or cDNA. Cell lines were identified with suspected defects in the regulatory regions of transfected genes in addition to cell lines which lacked recombinant genes. Also, "false-positive" cell lines were generated which were able to overcome the GS selection pressure without producing any recombinant antibody. This article discusses these findings in relation to vector design. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17001634     DOI: 10.1002/bit.21119

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  10 in total

1.  Construction strategies for developing expression vectors for recombinant monoclonal antibody production in CHO cells.

Authors:  Yan-Mei Li; Zheng-Wei Tian; Dan-Hua Xu; Xiao-Yin Wang; Tian-Yun Wang
Journal:  Mol Biol Rep       Date:  2018-09-06       Impact factor: 2.316

2.  Dynamics of unfolded protein response in recombinant CHO cells.

Authors:  Kamal Prashad; Sarika Mehra
Journal:  Cytotechnology       Date:  2014-02-07       Impact factor: 2.058

3.  Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.

Authors:  Jake Chng; Tianhua Wang; Rui Nian; Ally Lau; Kong Meng Hoi; Steven C L Ho; Peter Gagnon; Xuezhi Bi; Yuansheng Yang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

4.  Towards the molecular characterization of the stable producer phenotype of recombinant antibody-producing NS0 myeloma cells.

Authors:  Y Prieto; L Rojas; L Hinojosa; I González; D Aguiar; K de la Luz; A Castillo; R Pérez
Journal:  Cytotechnology       Date:  2011-03-20       Impact factor: 2.058

5.  Identifying bottlenecks in transient and stable production of recombinant monoclonal-antibody sequence variants in Chinese hamster ovary cells.

Authors:  Megan Mason; Bernadette Sweeney; Katharine Cain; Paul Stephens; Susan T Sharfstein
Journal:  Biotechnol Prog       Date:  2012-05-21

6.  Comprehensive characterization of glutamine synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal antibodies.

Authors:  Soo Min Noh; Seunghyeon Shin; Gyun Min Lee
Journal:  Sci Rep       Date:  2018-03-29       Impact factor: 4.379

7.  Intraclonal protein expression heterogeneity in recombinant CHO cells.

Authors:  Warren Pilbrough; Trent P Munro; Peter Gray
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

8.  Comparison of internal ribosome entry site (IRES) and Furin-2A (F2A) for monoclonal antibody expression level and quality in CHO cells.

Authors:  Steven C L Ho; Muriel Bardor; Bin Li; Jia Juan Lee; Zhiwei Song; Yen Wah Tong; Lin-Tang Goh; Yuansheng Yang
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

9.  Expression of antibodies using single open reading frame (sORF) vector design: Demonstration of manufacturing feasibility.

Authors:  Wendy R Gion; Rachel A Davis-Taber; Dean A Regier; Emma Fung; Limary Medina; Ling C Santora; Sahana Bose; Alexander V Ivanov; Barbara A Perilli-Palmer; Chris M Chumsae; Joseph G Matuck; Yune Z Kunes; Gerald R Carson
Journal:  MAbs       Date:  2013-05-31       Impact factor: 5.857

10.  Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line.

Authors:  E V Voronina; Y A Seregin; N A Litvinova; V I Shvets; R R Shukurov
Journal:  Springerplus       Date:  2016-09-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.